298 related articles for article (PubMed ID: 28725324)
1. Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure.
Vinod P; Krishnappa V; Chauvin AM; Khare A; Raina R
Cardiol Res; 2017 Jun; 8(3):87-95. PubMed ID: 28725324
[TBL] [Abstract][Full Text] [Related]
2. Vaptans: A new option in the management of hyponatremia.
Aditya S; Rattan A
Int J Appl Basic Med Res; 2012 Jul; 2(2):77-83. PubMed ID: 23776817
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of vasopressin receptor antagonists.
Ali F; Guglin M; Vaitkevicius P; Ghali JK
Drugs; 2007; 67(6):847-58. PubMed ID: 17428103
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin receptor antagonists and their role in clinical medicine.
Narayen G; Mandal SN
Indian J Endocrinol Metab; 2012 Mar; 16(2):183-91. PubMed ID: 22470853
[TBL] [Abstract][Full Text] [Related]
5. [Vasopressin receptor antagonists: the vaptans].
Villabona C
Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients.
Nodari S; Jao GT; Chiong JR
Int J Nephrol Renovasc Dis; 2010; 3():51-60. PubMed ID: 21694929
[TBL] [Abstract][Full Text] [Related]
7. Clinical review: the use of vaptans in clinical endocrinology.
Peri A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
[TBL] [Abstract][Full Text] [Related]
8. Conivaptan: Evidence supporting its therapeutic use in hyponatremia.
Li-Ng M; Verbalis JG
Core Evid; 2010 Jun; 4():83-92. PubMed ID: 20694067
[TBL] [Abstract][Full Text] [Related]
9. AVP receptor antagonists as aquaretics: review and assessment of clinical data.
Verbalis JG
Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S24-33. PubMed ID: 16970150
[TBL] [Abstract][Full Text] [Related]
10. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
11. Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.
Veeraveedu PT; Palaniyandi SS; Yamaguchi K; Komai Y; Thandavarayan RA; Sukumaran V; Watanabe K
Drug Discov Today; 2010 Oct; 15(19-20):826-41. PubMed ID: 20708094
[TBL] [Abstract][Full Text] [Related]
12. [Use of "Vaptans" in treatment of hyponatremia].
Tanındı A; Töre HF
Turk Kardiyol Dern Ars; 2015 Apr; 43(3):292-301. PubMed ID: 25906004
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin antagonists in heart failure.
Golestaneh L; Talreja A; Le Jemtel TH
Curr Heart Fail Rep; 2004 Dec; 1(4):190-6. PubMed ID: 16036044
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin and vasopressin receptor antagonists in heart failure.
Oghlakian G; Klapholz M
Cardiol Rev; 2009; 17(1):10-5. PubMed ID: 19092365
[TBL] [Abstract][Full Text] [Related]
15. Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
Lin TE; Adams KF; Patterson JH
Heart Fail Clin; 2014 Oct; 10(4):607-20. PubMed ID: 25217436
[TBL] [Abstract][Full Text] [Related]
16. Management of Hyponatremia in Heart Failure: Practical Considerations.
Şorodoc V; Asaftei A; Puha G; Ceasovschih A; Lionte C; Sîrbu O; Bologa C; Haliga RE; Constantin M; Coman AE; Petriș OR; Stoica A; Şorodoc L
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675801
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremia in Heart Failure: Pathogenesis and Management.
Rodriguez M; Hernandez M; Cheungpasitporn W; Kashani KB; Riaz I; Rangaswami J; Herzog E; Guglin M; Krittanawong C
Curr Cardiol Rev; 2019; 15(4):252-261. PubMed ID: 30843491
[TBL] [Abstract][Full Text] [Related]
18. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the understanding of water metabolism in heart failure.
Schrier RW; Martin PY
Adv Exp Med Biol; 1998; 449():415-26. PubMed ID: 10026833
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin dysregulation and hyponatremia in hospitalized patients.
Multz AS
J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
